6TCS
Crystal structure of the omalizumab scFv
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | DIAMOND BEAMLINE I24 |
| Synchrotron site | Diamond |
| Beamline | I24 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2014-02-01 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 0.9686 |
| Spacegroup name | P 31 2 1 |
| Unit cell lengths | 73.909, 73.909, 117.763 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 56.237 - 2.300 |
| R-factor | 0.1794 |
| Rwork | 0.178 |
| R-free | 0.20620 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6tcm |
| RMSD bond length | 0.004 |
| RMSD bond angle | 0.683 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 64.010 | 2.380 |
| High resolution limit [Å] | 2.300 | 2.300 |
| Rmerge | 0.259 | 2.248 |
| Rpim | 0.121 | 1.064 |
| Number of reflections | 17055 | 1655 |
| <I/σ(I)> | 6.2 | 2.5 |
| Completeness [%] | 99.8 | 99.9 |
| Redundancy | 5.5 | 5.2 |
| CC(1/2) | 0.974 | 0.597 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 5.6 | 291 | 0.1M tri-sodium citrate pH5.6, 15% PEG 4000 and 0.2M ammonium sulphate. Crystals were cryoprotected with 0.1M tri-sodium citrate pH5.6, 30% PEG 4000 and 0.2M ammonium sulphate |






